Scaling patient engagement strategies in precision medicine trials [whitepaper]

As patient engagement continues to emerge as a powerful tool for enabling the success of precision medicine trials, the integration of genomic data within healthcare and the need to secure stakeholder investment in long-term relationship-building strategies have never been more urgent. In March 2025, Sano hosted a discussion with key opinion leaders across the pharma and biotech sector to explore how they approach patient engagement in this breakthrough field. 

The extensive discussion focused on how integrating new technologies, patient education, and a collaborative approach to data sharing and regulatory frameworks will underpin the future success of precision medicine efforts.

In our latest whitepaper, “Scaling patient engagement strategies in precision medicine trials: Technology, integration, and regulatory development” we dive into the key discussion points and cover:

• Patient-centric engagement: The importance of relationship-building strategies, the critical role of patient voice and education, and how to accelerate adoption within industry 
• Uncharted territory: From investment hurdles to interoperability and standardization
• Big data: Characterizing rare patient populations, data sharing frameworks and principles for cross-organizational collaboration
• Cost challenges: From implementing wearables to investing in long term government strategies
• An international approach: The power of collaboration and the impact of international investment and policy models

The whitepaper highlights how patient engagement strategies and international collaboration are changing traditional approaches to study design, enabling dynamic adjustment and data sharing, improving retention rates and patient experience - and ultimately leading to increased likelihood of trial success.

Interested in more insights on how to integrate impactful patient engagement strategies into your latest study? Download the whitepaper to explore how a focus on patient education and bringing patient voices to the study design and development process can significantly improve enrollment and retention rates in precision medicine trials.